Pharmacists to protest against plan to re-categorize some in vitro tests

Published: 2013-09-02 06:58:00

Updated: 2013-09-02 06:58:00

The Korean Pharmaceutical Association (KPA) has vowed to protest the government's plan to "re-categorize" some of in vitro diagnostic testers as part of measures to reduce customers' inconvenience in buying such medical devices.

The reaction came after the Ministry of Food and Drug Safety (MF...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK